CAJ | 학술논문

乳腺癌是全身性疾病,通过手术、放疗、化疗、内分泌等综合治疗可提高疗效.近年乳腺癌新辅助化疗(NCT)引起了肿瘤学界极大的兴趣,一系列的临床研究都希望这一疗法不但能提高保乳,而且能延长总生存期.现就NCT在乳腺癌治疗中的研究进展作一综述.
유선암시전신성질병,통과수술、방료、화료、내분비등종합치료가제고료효.근년유선암신보조화료(NCT)인기료종류학계겁대적흥취,일계렬적림상연구도희망저일요법불단능제고보유,이차능연장총생존기.현취NCT재유선암치료중적연구진전작일종술.
Breast cancer is a systemic disease, only through multidisciplinary treatment including surgery, radiotherapy, chemotherapy, endocrine, can we enhance its effectiveness. In recent years, neoadjuvant chemotherapy for breast cancer has aroused great interest in tumor academia. We hope that this therapy can not only improve breast conservation rate, but also extend the overall survival through a series of clinical studies. This review presents the research progress of neoadjuvant chemotherapy for breast cancer.